Alnylam Pharma (ALNY) Announces Retirement of Steven Paul from Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. TMUS
9. SPY
10. SBUX

Go back to Alnylam Pharma (ALNY) Announces Retirement of Steven Paul from Board

Alnylam Announces Retirement of Steven Paul, M.D. from Board of Directors

April 5, 2022 4:00 PM EDT

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced that Steven Paul, M.D. is retiring from the Board of Directors effective April 16, 2022.

Dr. Paul has served as a member of the Alnylam Board of Directors since September 2010. He brought to the Board more than... More